Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-Center, Placebo- and Active-Controlled, Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

NCT04998981 is registered in ClinicalTrials.gov with Kowa Company, Ltd. as lead sponsor.

NCT NCT04998981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04998981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-Center, Placebo- and Active-Controlled, Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
Lead sponsor
Kowa Company, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 17, 2021
Completion date
February 2, 2023
Enrollment
353 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia